Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Erika Carmel-TechXTAE:ERKA 32 Gross Margin % is 79.82% as of Dec. 2025, which is 8% below its 10-year median of 86.82. GuruFocus rates XTAE:ERKA with a GF Score™ of 32/100 and a GF Value™ of ₪0.55 (Fairly Valued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Erika Carmel-Tech ranks better than 79.01% on this metric.
Erika Carmel-Tech Ltd gross margin has been in long-term decline. The average rate of decline per year is -6.1%.
The historical rank and industry rank for Erika Carmel-Tech's Gross Margin % or its related term are showing as below:
XTAE:ERKA'
s Gross Margin % Range Over the Past 10 Years
Min: 68.62 Med: 86.82 Max: 91.37
Current: 69.29
During the past 8 years, the highestGross Margin % of Erika Carmel-Tech was 91.37%. The lowest was 68.62%. And the median was 86.82%.
XTAE:ERKA's Gross Margin % is ranked better than 79.01% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs XTAE:ERKA: 69.29
Erika Carmel-Tech had a gross margin of 79.82% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Erika Carmel-Tech was -6.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Erika Carmel-Tech had a gross margin of 79.82% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Erika Carmel-Tech Gross Margin % Related Terms
Erika Carmel-Tech Gross Margin % Historical Data
* Premium members only.
The historical data trend for Erika Carmel-Tech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:ERKA vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Erika Carmel-Tech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Erika Carmel-Tech Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Erika Carmel-Tech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Erika Carmel-Tech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Erika Carmel-Tech (XTAE:ERKA) has a Gross Margin % of 79.82% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Erika Carmel-Tech and its competitors. This is near median its historical median of 86.82. Over the past decade, Erika Carmel-Tech's Gross Margin % has ranged from 68.62 to 91.37. According to the industry distribution chart, Erika Carmel-Tech ranks #169 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 21%.
Is Erika Carmel-Tech's Gross Margin % too high?
Erika Carmel-Tech's current Gross Margin % of 79.82% is near median its 10-year median of 86.82. Over the past 10 years, this metric has ranged from a low of 68.62 to a high of 91.37. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Erika Carmel-Tech's value of 79.82% is 53.3% above this industry median. Based on the distribution chart, Erika Carmel-Tech ranks #169 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Erika Carmel-Tech has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Erika Carmel-Tech's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Erika Carmel-Tech ranks #169 out of 805 companies for Gross Margin %. This places Erika Carmel-Tech in the top 21% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. Erika Carmel-Tech's value of 79.82% is 53.3% above this benchmark. Historically, Erika Carmel-Tech's own Gross Margin % has ranged from 68.62 to 91.37 over the past decade. While the company's 10-year median is 86.82 vs. the industry median of 52.07, Erika Carmel-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Erika Carmel-Tech's current Gross Margin % of 79.82% is 53.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Erika Carmel-Tech and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Erika Carmel-Tech's current Gross Margin % is 79.82%, which is near median its own 10-year median of 86.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Erika Carmel-Tech stock overvalued right now?
Based on GuruFocus' analysis, Erika Carmel-Tech (XTAE:ERKA) is currently considered Fairly Valued. The stock's GF Value™ is ₪0.55, compared to a current price of ₪0.52 — trading 6.4% below its estimated fair value. The current Gross Margin % is 79.82%, which is near median its 10-year median of 86.82 and 53.3% above the Medical Devices & Instruments industry median of 52.07. Erika Carmel-Tech's overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Erika Carmel-Tech (XTAE:ERKA), the current Gross Margin % is 79.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Erika Carmel-Tech (XTAE:ERKA) Overvalued in 2026?
Based on GuruFocus' analysis, Erika Carmel-Tech stock appears to be undervalued.
The current stock price of ₪0.52 is trading 6.4% below its estimated GF Value™ of ₪0.55.
GuruFocus considers Erika Carmel-Tech to be Fairly Valued.
Key valuation signals for XTAE:ERKA:
Gross Margin %: 79.82% (near median its 10-year median of 86.82)
GF Value™: ₪0.55 vs. price of ₪0.52 (6.4% below fair value)
Industry Position: 53.3% above the Medical Devices & Instruments median (#169 of 805)
No single metric tells the full story. See the XTAE:ERKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Erika Carmel-Tech Ltd Formerly Erika B-Cure Laser Ltd is engaged in the development and production of laser devices for the treatment of pain and wounds. Its devices provide treatment for Knee Pain, Lower Back Pain, Neck Pain, Shoulder Pain, Finger Joint pain, and Burns.
32GF Score
Get the complete analysis for XTAE:ERKA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ERKA has been successfully added to your 
